Skip to main content English


Katharina Krenn Katharina KrennHead of the lung research group

Department of Anaesthesia, Intensive Care Medicine and Pain Medicine (Division of General Anaesthesia and Intensive Care Medicine)
Position: Consultant

ORCID: 0000000269509361
T +43 1 4040041020


Acute Lung Injury; Clinical Trial; Intensive Care; Renin-Angiotensin System

Research group(s)

Research interests

My research focuses are clinical trials in critical care medicine, acute lung injury/acute respiratory distress syndrome and the renin-angiotensin-system in critical illness and the perioperative period. Currently, my research group is participating in the multicenter phase IIb trial on AP301/solnatide as inhalation therapy for ARDS.


  • The angiotensin metabolite profile after subarachnoid hemorrhage (2021)
    Source of Funding: FWF (Austrian Science Fund), KLIF
    Principal Investigator

Selected publications

  1. Krenn, K. et al., 2017. Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial. Critical Care, 21(1). Available at:
  2. Krenn, K. et al., 2015. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans. The Journal of Thoracic and Cardiovascular Surgery, 149(4), pp.1194-1202. Available at:
  3. Krenn, K. et al., 2007. Recipient Vascular Endothelial Growth Factor Serum Levels Predict Primary Lung Graft Dysfunction. American Journal of Transplantation, 7(3), pp.700-706. Available at: